Predictive validation of existing bleeding and thromboembolic scores in elderly patients with comorbid atrial fibrillation and acute coronary syndrome.
10.26599/1671-5411.2023.05.001
- Author:
Hong-Hong ZHANG
1
;
Qi LIU
2
;
Hai-Jing ZHAO
1
;
Ya-Ni YU
3
,
4
,
5
;
Liu-Yang TIAN
1
;
Ying-Yue ZHANG
1
;
Zi-Hao FU
1
;
Li ZHENG
1
;
Yue ZHU
1
;
Yu-Han MA
1
;
Shuang LI
6
;
Yang-Yang MA
6
;
Yu-Qi LIU
3
,
4
,
5
Author Information
1. Medical School of Chinese PLA, Beijing, China.
2. Department of Cardiology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
3. Department of Cardiology & National Clinical Research Center of Geriatrics Disease
4. Beijing Key Laboratory of Chronic Heart Failure Precision Medicine
5. National Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.
6. Department of Information, Chinese PLA General Hospital, Beijing, China.
- Publication Type:Journal Article
- From:
Journal of Geriatric Cardiology
2023;20(5):330-340
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:The validation of various risk scores in elderly patients with comorbid atrial fibrillation (AF) and acute coronary syndrome (ACS) has not been reported. The present study compared the predictive performance of existing risk scores in these patients.
METHODS:A total of 1252 elderly patients with AF and ACS comorbidities (≥ 65 years old) were consecutively enrolled from January 2015 to December 2019. All patients were followed up for one year. The predictive performance of risk scores in predicting bleeding and thromboembolic events was calculated and compared.
RESULTS:During the 1-year follow-up, 183 (14.6%) patients had thromboembolic events, 198 (15.8%) patients had BARC class ≥ 2 bleeding events, and 61 (4.9%) patients had BARC class ≥ 3 bleeding events. For the BARC class ≥ 3 bleeding events, discrimination of the existing risk scores was low to moderate, PRECISE-DAPT (C-statistic: 0.638, 95% CI: 0.611-0.665), ATRIA (C-statistic: 0.615, 95% CI: 0.587-0.642), PARIS-MB (C-statistic: 0.612, 95% CI: 0.584-0.639), HAS-BLED (C-statistic: 0.597, 95% CI: 0.569-0.624) and CRUSADE (C-statistic: 0.595, 95% CI: 0.567-0.622). However, the calibration was good. PRECISE-DAPT showed a higher integrated discrimination improvement (IDI) than PARIS-MB, HAS-BLED, ATRIA, and CRUSADE (P < 0.05) and the best decision curve analysis (DCA). For thromboembolic events, the discrimination of GRACE (C-statistic: 0.636, 95% CI: 0.608-0.662) was higher than CHA2DS2-VASc (C-statistic: 0.612, 95% CI: 0.584-0.639), OPT-CAD (C-statistic: 0.602, 95% CI: 0.574-0.629) and PARIS-CTE (C-statistic: 0.595, 95% CI: 0.567-0.622). The calibration was good. Compared to OPT-CAD and PARIS-CTE, the IDI of the GRACE score slightly improved (P < 0.05). However, NRI analysis showed no significant difference. DCA showed that the clinical practicability of thromboembolic risk scores was similar.
CONCLUSIONS:The discrimination and calibration of existing risk scores in predicting 1-year thromboembolic and bleeding events were unsatisfactory in elderly patients with comorbid AF and ACS. PRECISE-DAPT showed higher IDI and DCA than other risk scores in predicting BARC class ≥ 3 bleeding events. The GRACE score showed a slight advantage in predicting thrombotic events.
